In human lung adenocarcinoma, the hypermethylation of GRK6 promoter, the knockdown of GRK6 gene or a decreased expression of GRK6 protein was shown to correlate with an enhanced metastatic potentials and poorer prognosis [15, 16]. The gene discussed is GRK6; the disease is lung adenocarcinoma.